Patents by Inventor Vladimir Konstantinovich Bojenko

Vladimir Konstantinovich Bojenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150174191
    Abstract: The present invention relates to the field of biotechnology and medicine, in particular to a pharmaceutical composition having an antiproliferative activity and comprising an chimeric peptide and to a method of treating oncologic diseases, which includes introducing the chimerical peptide into a mammal requiring such treatment. The objective of the of invention is the development of a preparation that effectively penetrates the target cells and has a high cytostatic and cytotoxic activity.
    Type: Application
    Filed: January 16, 2015
    Publication date: June 25, 2015
    Applicant: OOO "METAMAX"
    Inventor: Vladimir Konstantinovich Bojenko
  • Patent number: 8969515
    Abstract: The proposed pharmaceutical compositions and methods connected thereto relate to the field of biotechnology and medicine, in particular to pharmaceutical compositions having an antiproliferative activity, and to a method of treating oncologic diseases, which includes introducing the aforementioned chimerical peptide into a mammal requiring such treatment. The object of the proposed compositions and methods is the development of a preparation that effectively penetrates the target cells and has a high cytostatic and cytotoxic action.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: March 3, 2015
    Assignee: OOO “MetaMax”
    Inventor: Vladimir Konstantinovich Bojenko
  • Publication number: 20140051644
    Abstract: The proposed pharmaceutical compositions and methods connected thereto relate to the field of biotechnology and medicine, in particular to pharmaceutical compositions having an antiproliferative activity, and to a method of treating oncologic diseases, which includes introducing the aforementioned chimerical peptide into a mammal requiring such treatment. The object of the proposed compositions and methods is the development of a preparation that effectively penetrates the target cells and has a high cytostatic and cytotoxic action.
    Type: Application
    Filed: May 20, 2011
    Publication date: February 20, 2014
    Inventor: Vladimir Konstantinovich Bojenko